Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy
- DOI
- 10.1001/jamaoncol.2019.4794
- Published
- 2020-03-01
- Container
- JAMA Oncology
- Publisher
- American Medical Association (AMA)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1001/jamaoncol.2019.4794,
title = {Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy},
author = {Joseph A. Sparano and Robert J. Gray and Della F. Makower and Kathy S. Albain and Thomas J. Saphner and Sunil S Badve and Lynne I. Wagner and Virginia G. Kaklamani and Maccon M. Keane and Henry L. Gomez and Pavan S. Reddy and Timothy F. Goggins and Ingrid A. Mayer and Deborah L. Toppmeyer and Adam M. Brufsky and Matthew P. Goetz and Jeffrey L. Berenberg and Catalin Mahalcioiu and Christine Desbiens and Daniel F. Hayes and Elizabeth C. Dees and Charles E. Geyer and John A. Olson and William C Wood and Tracy Lively and Soonmyung Paik and Matthew J. Ellis and Jeffrey Abrams and George W. Sledge},
year = {2020},
journal = {JAMA Oncology},
doi = {10.1001/jamaoncol.2019.4794},
url = {https://doi.org/10.1001/jamaoncol.2019.4794}
}RIS
TY - JOUR TI - Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy AU - Joseph A. Sparano AU - Robert J. Gray AU - Della F. Makower AU - Kathy S. Albain AU - Thomas J. Saphner AU - Sunil S Badve AU - Lynne I. Wagner AU - Virginia G. Kaklamani AU - Maccon M. Keane AU - Henry L. Gomez AU - Pavan S. Reddy AU - Timothy F. Goggins AU - Ingrid A. Mayer AU - Deborah L. Toppmeyer AU - Adam M. Brufsky AU - Matthew P. Goetz AU - Jeffrey L. Berenberg AU - Catalin Mahalcioiu AU - Christine Desbiens AU - Daniel F. Hayes AU - Elizabeth C. Dees AU - Charles E. Geyer AU - John A. Olson AU - William C Wood AU - Tracy Lively AU - Soonmyung Paik AU - Matthew J. Ellis AU - Jeffrey Abrams AU - George W. Sledge PY - 2020 JO - JAMA Oncology DO - 10.1001/jamaoncol.2019.4794 UR - https://doi.org/10.1001/jamaoncol.2019.4794 ER -
APA
Sparano, J. A., Gray, R. J., Makower, D. F., Albain, K. S., Saphner, T. J., Badve, S. S., Wagner, L. I., Kaklamani, V. G., Keane, M. M., Gomez, H. L., Reddy, P. S., Goggins, T. F., Mayer, I. A., Toppmeyer, D. L., Brufsky, A. M., Goetz, M. P., Berenberg, J. L., Mahalcioiu, C., Desbiens, C., Hayes, D. F., Dees, E. C., Geyer, C. E., Olson, J. A., Wood, W. C., Lively, T., Paik, S., Ellis, M. J., Abrams, J., & Sledge, G. W. (2020). Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy. JAMA Oncology. https://doi.org/10.1001/jamaoncol.2019.4794
Source records
- crossref · retrieved 2026-09-26T13:29:53.318Z